Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • roche

    Tag: roche

    You Searched For "roche"
    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

    Medical Dialogues Bureau9 April 2020 7:00 AM GMT
    New Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
    Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

    Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients

    Medical Dialogues Bureau29 March 2020 6:45 AM GMT
    Venclexta/Venclyxto is being developed by AbbVie and Roche.
    Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

    Genentech,BARDA gets USFDA nod for Actemra Clinical Trial in COVID-19 patients

    Medical Dialogues Bureau28 March 2020 4:45 AM GMT
    US: Genentech, a member of the Roche Group has announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind,...
    Roche Diagnostics India first private firm to get COVID-19 test approval

    Roche Diagnostics India first private firm to get COVID-19 test approval

    Medical Dialogues Bureau20 March 2020 4:30 AM GMT
    New Delhi: Roche Diagnostics India has received the license from the country's drug regulator DCGI for its ''Cobas SARS CoV-2'' diagnostic test kit,...
    Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia

    Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia

    Medical Dialogues Bureau20 March 2020 4:30 AM GMT
    Basel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled...
    Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

    Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

    Medical Dialogues Bureau15 March 2020 7:19 AM GMT
    Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2...
    Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer

    Roche gets USFDA nod for CINtec PLUS Cytology test for cervical cancer

    Medical Dialogues Bureau12 March 2020 6:42 AM GMT
    CINtec PLUS Cytology provides definitive information about which HPV-positive women may benefit most from immediate referral to colposcopy versus...
    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Farhat Nasim10 Dec 2019 7:37 AM GMT
    Now officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

    Medical Dialogues Bureau29 Nov 2019 3:45 AM GMT
    Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Medical Dialogues Bureau26 Nov 2019 3:58 AM GMT
    Roche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Medical Dialogues Bureau25 Nov 2019 3:30 AM GMT
    Median overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    Medical Dialogues Bureau22 Nov 2019 6:55 AM GMT
    "Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X